(b)(4) based on the available information, this event is deemed to be a serious injury.No lot number or product evaluation sample is available.A detailed investigation or batch review cannot be conducted.A previous non-conformance is applicable to this complaint and is closed.No corrective actions have been identified as a result of this investigation; therefore this evaluation will be closed and will be monitored through our post market product monitoring review process.No further information was available at the time of the report.Should additional information become available, a follow-up report will be submitted.Reported to the fda on february 23, 2016.(b)(4).
|